The global Oxytocic Pharmaceuticals market is poised for significant growth, as indicated by recent market analysis. Valued at USD 110.26 billion in 2022, this dynamic market is expected to reach an impressive USD 204.09 billion by 2030, showcasing a robust Compound Annual Growth Rate (CAGR) of 8% over the forecast period from 2023 to 2030. Key Drivers of Growth: Increasing Focus on Maternal...